A CME Proceedings Newsletter for Advanced Practice Providers: Regional CSID APP Leadership Summits

To claim 1.0 credit for this activity, please visit:

Release date: March 1, 2024

Expiration date: March 1, 2025

(Download includes CME accreditation material)

Target Audience

The initiative's total targeted reach is 5,000 health care professionals. including nurse practitioners, nurses, and physician assistants.

Program Overview

The joint providership of Medical Education Resources (MER) and the GI Health Foundation (GiHF) proposes to develop an accredited proceedings e-Newsletter on the management of patients with CSID. In addition to the content discussed during the CSID leadership summits and virtual mentorship sessions, additional expert opinions, recent publications, abstracts, and presentations from congress meetings will be reviewed as part of the e-Newsletter development process.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Describe the prevalence of CSID in patients with common GI disorders
  • Incorporate current diagnostic strategies to differentiate CSID from other causes of persistent diarrhea seen in clinical practice, particularly among patients with suspected IBS
  • Summarize benefits and limitations of current treatment strategies for CSID


Patrick Horne, NP
Daksesh Patel, DO
Christina Hanson, FNP-C
Jennifer Geremia, PA-C
Amy Ladewski, PA-C
Sharon Rimon, RNP-BC

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and GiHF. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Credit

Medical Education Resources designates this enduring material for a maximum of 1.0 ANCC nursing contact hour. Nurses will be awarded contact hours upon successful completion of the activity.

Physician Assistant Credit

Medical Education Resources has been authorized by the American Academy of Physician Assistants (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME Credits. Physician Assistants should only claim credit commensurate with the extent of their participation.

Disclosure of Relevant Financial Relationships

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.


    Daksesh Patel, DO
  • Speaker's Bureau – QOL Medical
  • Patrick Horne, NP
  • No relationships to disclose.
  • Julie Messick, PharmD
  • No relationships to disclose.
  • Christina Hanson, FNP-C
  • Speakers' Bureau: Salix Speaker Bureau and Ad Board, Ardelyx Speaker Bureau, Intercept Speaker Bureau and Ad Board, Sanofi Ad Board
  • Planners at Gastroenterology & Hepatology Advanced Practice Providers (GHAPP) and Medical Education Resources (MER) - no financial relationships to disclose.
  • Jennifer Geremia, PA-C
  • Consulting Fees – Abbvie, Pfizer, Salix
  • Speakers' Bureau – Bristol Meyers Squibb, Abbvie, Eli Lilly
  • Amy Ladewski, PA-C
  • Consulting Fees: Ardelyx, QOL
  • Speakers' Bureau: Ardelyx, Salix
  • Sharon Rimon, RNP-BC
  • Consulting Fees: AbbVie, Pfizer, Eli Lilly, Ferring, Salix, Janssen
  • Speakers' Bureau: AbbVie, Pfizer, Eli Lilly, Ferring, Salix, Janssen

Method of Participation

There are no fees for participating in and receiving credit for this activity. During the period March 1, 2024 through March 1, 2025 , participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest by recording the best answer to each question, and 4) complete the evaluation form. A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 75% or better. Please visit https://education.gihealthfoundation.org/content/cme-proceedings-newsletter-advanced-practice-providers-regional-csid-app-leadership-summits to complete the posttest and evaluation.




The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, the GI Health Foundation, and/or QOL Medical LLC. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Fee Information

There is no fee for this educational activity.

This activity is jointly provided by Medical Education Resources and the Gi Health Foundation

Supported by an educational grant from QOL Medical LLC.